Occurrence of Significant Event. The restrictions contained in Sections 6.1(b), (c) and (d) shall be suspended and shall not apply to or otherwise restrict the Investor’s actions in respect of the Company’s securities for so long as a Significant Event has occurred and is continuing.
Appears in 2 contracts
Sources: Common Stock Purchase Agreement (Amgen Inc), Common Stock Purchase Agreement (Cytokinetics Inc)
Occurrence of Significant Event. The restrictions contained in Sections 6.1(b), (c6.1(c) and (d6.1(d) shall be suspended and shall not apply to or otherwise restrict the Investor’s actions in respect of the Company’s securities for so long as a Significant Event has occurred and is continuing.
Appears in 2 contracts
Sources: Series E Preferred Stock Purchase Agreement (Aduro Biotech, Inc.), Common Stock Purchase Agreement (Aduro Biotech, Inc.)
Occurrence of Significant Event. The restrictions contained in Sections 6.1(b), (c) and (dc) shall be suspended and shall not apply to or otherwise restrict the Investor’s actions in respect of the Company’s securities for so long as a Significant Event has occurred and is continuing.
Appears in 2 contracts
Sources: Common Stock Purchase Agreement (Cytokinetics Inc), Common Stock Purchase Agreement (Cytokinetics Inc)
Occurrence of Significant Event. The restrictions contained in Sections 6.1(b), (c) and (d6.1(c) shall be suspended and shall not apply to or otherwise restrict the Investor’s actions in respect of the Company’s securities for so long as a Significant Event has occurred and is continuing.
Appears in 2 contracts
Sources: Common Stock Purchase Agreement (Aduro Biotech, Inc.), Common Stock Purchase Agreement (Cytokinetics Inc)
Occurrence of Significant Event. The restrictions contained in Sections Section 6.1(b), (c) and (d) shall be suspended and shall not apply to or otherwise restrict the Investor’s actions in respect of the Company’s securities for so long as a Significant Event has occurred and is continuing.
Appears in 1 contract
Occurrence of Significant Event. The restrictions contained in Sections 6.1(b), (c) and (dSection 7.1(b) shall be suspended and shall not apply to or otherwise restrict the Investor’s actions in respect of the Company’s securities for so long as a Significant Event has occurred and is continuing.
Appears in 1 contract
Sources: Common Stock Option Purchase Agreement (Cytokinetics Inc)
Occurrence of Significant Event. The restrictions contained in Sections Section 6.1(b), (c) and (d) shall be suspended and shall not apply to or otherwise restrict the an Investor’s actions in respect of the Company’s securities for so long as a Significant Event has occurred and is continuing.
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Eiger BioPharmaceuticals, Inc.)